These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 36869060)

  • 41. Long-Term Symptoms after Mild Coronavirus Disease in Healthy Healthcare Professionals: A 12-Month Prospective Cohort Study.
    da Costa E Silva GR; Moura WÉA; Dos Santos KC; Gomes DO; Bandeira GN; Guimarães RA; Rosso CFW; Bazilio GS; Leite VRMC; Caetano KAA; Carneiro MADS; Teles SA
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient-reported functional outcomes 30 days after hospitalization for COVID-19.
    Qin ES; Gold LS; Hough CL; Katz PP; Bunnell AE; Wysham KD; Andrews JS
    PM R; 2022 Feb; 14(2):173-182. PubMed ID: 34585858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fatigue has a prominent impact on health lasting 12-weeks after COVID-19 infection.
    Yıldız BP; Hattatoğlu DG; Aydin C; Darçın G
    Malawi Med J; 2023 Jun; 35(2):124-129. PubMed ID: 38264167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19.
    Munblit D; Bobkova P; Spiridonova E; Shikhaleva A; Gamirova A; Blyuss O; Nekliudov N; Bugaeva P; Andreeva M; DunnGalvin A; Comberiati P; Apfelbacher C; Genuneit J; Avdeev S; Kapustina V; Guekht A; Fomin V; Svistunov AA; Timashev P; Subbot VS; Royuk VV; Drake TM; Hanson SW; Merson L; Carson G; Horby P; Sigfrid L; Scott JT; Semple MG; Warner JO; Vos T; Olliaro P; Glybochko P; Butnaru D;
    Clin Exp Allergy; 2021 Sep; 51(9):1107-1120. PubMed ID: 34351016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility of the 30 s Sit-to-Stand Test in the Telehealth Setting and Its Relationship to Persistent Symptoms in Non-Hospitalized Patients with Long COVID.
    Núñez-Cortés R; Flor-Rufino C; Martínez-Arnau FM; Arnal-Gómez A; Espinoza-Bravo C; Hernández-Guillén D; Cortés-Amador S
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study.
    Fumagalli C; Zocchi C; Tassetti L; Silverii MV; Amato C; Livi L; Giovannoni L; Verrillo F; Bartoloni A; Marcucci R; Lavorini F; Fumagalli S; Ungar A; Olivotto I; Rasero L; Fattirolli F; Marchionni N;
    Eur J Intern Med; 2022 Mar; 97():36-41. PubMed ID: 34903448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
    Taquet M; Dercon Q; Luciano S; Geddes JR; Husain M; Harrison PJ
    PLoS Med; 2021 Sep; 18(9):e1003773. PubMed ID: 34582441
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring risk factors for persistent neurocognitive sequelae after hospitalization for COVID-19.
    Ch'en PY; Gold LS; Lu Q; Ye T; Andrews JS; Patel P
    Ann Clin Transl Neurol; 2023 Jul; 10(7):1200-1208. PubMed ID: 37265172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients.
    Abel KM; Carr MJ; Ashcroft DM; Chalder T; Chew-Graham CA; Hope H; Kapur N; McManus S; Steeg S; Webb RT; Pierce M
    JAMA Netw Open; 2021 Nov; 4(11):e2134803. PubMed ID: 34783824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19.
    Machado FVC; Meys R; Delbressine JM; Vaes AW; Goërtz YMJ; van Herck M; Houben-Wilke S; Boon GJAM; Barco S; Burtin C; van 't Hul A; Posthuma R; Franssen FME; Spies Y; Vijlbrief H; Pitta F; Rezek SA; Janssen DJA; Siegerink B; Klok FA; Spruit MA
    Health Qual Life Outcomes; 2021 Feb; 19(1):40. PubMed ID: 33536042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical features and predictors of severity in 1022 adults with COVID-19].
    Saldías Peñafiel F; Peñaloza Tapia A; Farías Nesvadba D; Farcas Oksenberg K; Reyes Sánchez A; Cortés Meza J; Lara Hernández B; Aguilera Fuenzalida P; Leiva Rodríguez I
    Rev Med Chil; 2020 Oct; 148(10):1387-1397. PubMed ID: 33844708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
    Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
    Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Post-acute COVID-19 syndrome in previously hospitalized patients.
    Eo Y; Chang SJ
    J Nurs Scholarsh; 2024 Jul; 56(4):517-530. PubMed ID: 38505990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Long COVID in Children: A Pediatric Center Experience].
    Demirbuğa A; Hançerli Törün S; Kaba Ö; Dede E; Mete Atasever N; Eryılmaz CC; Okay NS; Somer A
    Mikrobiyol Bul; 2023 Jan; 57(1):60-70. PubMed ID: 36636846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluating fatigue in patients recovering from COVID-19: validation of the fatigue severity scale and single item screening questions.
    Naik H; Shao S; Tran KC; Wong AW; Russell JA; Khor E; Nacul L; McKay RJ; Carlsten C; Ryerson CJ; Levin A
    Health Qual Life Outcomes; 2022 Dec; 20(1):170. PubMed ID: 36575437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of Long COVID symptoms in Bangladesh: a prospective Inception Cohort Study of COVID-19 survivors.
    Hossain MA; Hossain KMA; Saunders K; Uddin Z; Walton LM; Raigangar V; Sakel M; Shafin R; Hossain MS; Kabir MF; Faruqui R; Rana MS; Ahmed MS; Chakrovorty SK; Hossain MA; Jahid IK
    BMJ Glob Health; 2021 Dec; 6(12):. PubMed ID: 34906986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1-year quality of life and health-outcomes in patients hospitalised with COVID-19: a longitudinal cohort study.
    O'Brien K; Townsend L; Dowds J; Bannan C; Nadarajan P; Kent B; Murphy N; Sheill G; Martin-Loeches I; Guinan E
    Respir Res; 2022 May; 23(1):115. PubMed ID: 35509060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fatigue after COVID-19 in non-hospitalized patients according to sex.
    Mazurkiewicz I; Chatys-Bogacka Z; Slowik J; Klich-Raczka A; Fedyk-Lukasik M; Slowik A; Wnuk M; Drabik L
    Brain Behav; 2023 Feb; 13(2):e2849. PubMed ID: 36620918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution.
    Robineau O; Zins M; Touvier M; Wiernik E; Lemogne C; de Lamballerie X; Blanché H; Deleuze JF; Saba Villarroel PM; Dorival C; Nicol J; Gomes-Rima R; Correia E; Coeuret-Pellicer M; Druesne-Pecollo N; Esseddik Y; Ribet C; Goldberg M; Severi G; Carrat F;
    JAMA Netw Open; 2022 Nov; 5(11):e2240985. PubMed ID: 36350653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.